Biogen Inc (BIIB)

Total asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	9,835,600	9,993,300	9,971,500	10,104,600	10,173,400	10,363,200	10,633,600	10,819,500	10,981,700	11,100,500	11,697,700	12,604,300	13,444,600	14,263,300	14,487,300	14,422,400	14,377,900	14,232,900	14,071,800	13,811,600
Total assets	US$ in thousands	26,844,800	28,193,200	25,156,800	24,598,400	24,554,100	24,854,200	25,081,400	23,614,400	23,877,300	23,806,700	24,470,400	23,854,700	24,618,900	24,934,100	25,511,800	26,119,200	27,234,300	27,484,000	26,287,600	26,445,500
Total asset turnover		0.37	0.35	0.40	0.41	0.41	0.42	0.42	0.46	0.46	0.47	0.48	0.53	0.55	0.57	0.57	0.55	0.53	0.52	0.54	0.52

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $9,835,600K ÷ $26,844,800K
= 0.37

Biogen Inc's total asset turnover has shown some fluctuation over the past eight quarters. The ratio ranged from 0.35 to 0.46 during this period. In general, a higher total asset turnover indicates that the company is more efficient in generating sales revenue from its assets.

The trend for Biogen Inc's total asset turnover seems to have decreased slightly in the most recent quarters, with a decrease from 0.46 in Q1 2022 to 0.37 in Q4 2023. This may suggest a potential decrease in the company's efficiency in utilizing its assets to generate revenue.

It is important to further investigate the reasons behind this trend and assess whether it is a temporary fluctuation or a more persistent issue that could impact the company's financial performance and operational effectiveness in the future. Additionally, benchmarking Biogen Inc's total asset turnover against industry peers could provide further insights into its relative efficiency in managing assets.